ORMP
ORMP clinical trials: ORAMED PHARMACEUTICALS INC.
Every trial on ClinicalTrials.gov where ORAMED PHARMACEUTICALS INC. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 16
- Trials linked
- 13
- As lead sponsor
- 3
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
ORMP on the catalyst calendar · ORMP registry changes
- Primary completion Apr 25, 2027Sponsor estimatePhase 3NCT06731075A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus.Oramed, Ltd. · Type 2 Diabetes MellitusNot yet recruitingORMPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 27, 2022ActualPhase 2NCT04618744A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)Oramed, Ltd. · Diabetes Mellitus, Type 2CompletedORMPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 7, 2022ActualPhase 2NCT04564846A Study to Evaluate the Effect of ORMD-0801 in Patients With Type 2 Diabetes MellitusOramed, Ltd. · Diabetes Mellitus, Type 2CompletedORMPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 1, 2022ActualPhase 2NCT04616014A Study of Oral Insulin to Reduce Liver Fat Content in Type 2 Diabetes Patients With Nonalcoholic Steatohepatitis (NASH)Oramed, Ltd. · Nonalcoholic Steatohepatitis (NASH)CompletedORMPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 1, 2020ActualPhase 2NCT02653300A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH)Oramed, Ltd. · Non-Alcoholic Steatohepatitis (NASH)CompletedORMPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 13, 2023ActualPhase 3NCT04754334A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes MellitusOramed, Ltd. · T2DM (Type 2 Diabetes Mellitus)TerminatedORMPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 13, 2023ActualPhase 3NCT04606576Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes MellitusOramed, Ltd. · Type 2 Diabetes MellitusTerminatedORMPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 21, 2019ActualPhase 2NCT03467932A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes MellitusOramed, Ltd. · T2DM (Type 2 Diabetes Mellitus)CompletedORMPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 6, 2020ActualPhase 2NCT04150107A Study to Compare ORMD-0801 Once Daily to ORMD-0801 Three Times Daily in Subjects With Type 1 DiabetesOramed, Ltd. · Type 1 DiabetesCompletedORMPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 27, 2016ActualPhase 2NCT02496000Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes MellitusOramed, Ltd. · Diabetes Type 2CompletedORMPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 24, 2017ActualPhase 2NCT02954601A Study of Single and Multiple Doses of Oral Insulin or Placebo in Subjects With Type 2 Diabetes MellitusOramed, Ltd. · Type 2 Diabetes MellitusCompletedORMPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2014ActualPhase 2NCT02094534A Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin Capsules) on the Exogenous...Oramed, Ltd. · Diabetes Mellitus Type 1CompletedORMPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2013ActualPhase 2NCT01889667Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2...Oramed, Ltd. · Diabetes Mellitus Type 2CompletedORMPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2022Sponsor estimatePhase 3NCT04817215Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes MellitusKing Hamad University Hospital, Bahrain · Diabetes Mellitus, Type 2Unknown statusORMPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2017ActualPhase 2NCT02535715A Euglycemic Insulin Clamp Study in Type 1 Diabetic Patients With Oral Insulin (ORAMED)The University of Texas Health Science Center at San Antonio · Type 1 DiabetesCompletedORMPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2008ActualPhase 2NCT00867594Effectiveness of Oral Insulin in Unstable Type 1 Diabetes PatientsHadassah Medical Organization · Brittle Type I Diabetes MellitusCompletedORMPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 16 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner